• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NRX Pharmaceuticals, Inc. - Common Stock (NQ:NRXP)

2.905 +0.055 (+1.93%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 613,068
Open 2.910
Bid (Size) 2.930 (7,800)
Ask (Size) 2.950 (200)
Prev. Close 2.850
Today's Range 2.820 - 2.940
52wk Range 1.620 - 5.055
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
$11 Million Dollar Award for Robotic Magnetic Stimulation with Pharma Treatment for Resistant Depression Greatly Expands Application Potential for NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
October 01, 2026
Via Get News
Topics Intellectual Property
News headline image
NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression
September 30, 2026
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire

Performance

52-Week Range 42.5% below 52-week high
2.905
1.6252W Low 5.0552W High
1 Week 5.1% below 1-week high
2.821W Low 3.061W High

NRX Pharmaceuticals, Inc. - Common Stock (NRXP) traded between $1.62 and $5.05 over the past 52 weeks and last traded at $2.90, 42.5% below its 52-week high. Over the past week it ranged between $2.82 and $3.06.

Past 12 Months
+1.2%
-16.0%
-26.4%
+29.1%
+10.9%
-12.8%
1W +$0.03
1M -$0.56
3M -$1.04
6M +$0.65
YTD +$0.28
1Y -$0.43

NRXP was -12.8% over the past year, +29.1% over six months, +10.9% year to date, +1.2% in the last week.

12 Months vs Market
NRXP
-12.8%
DIA
+9.9%
SPY
+15.0%
QQQ
+23.7%
IWM
+15.4%

Over the past 12 months NRXP returned -12.8% versus DIA (Dow) +9.9%, SPY (S&P 500) +15.0%, QQQ (Nasdaq 100) +23.7% and IWM (Russell 2000) +15.4%.

Volume & Liquidity 0.69× 3-mo avg
Today 613,068 3-mo avg 886.6K
1W
730.7K
1M
667.0K
3M
886.6K
6M
1.1M
YTD
1.1M
1Y
920.5K

NRXP most recently traded 613,068 shares against a 3-month average daily volume of 886.6K.

More News

Read More
News headline image
NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine
September 15, 2026
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
First Interventional Psychiatry Use of FDA-Cleared Zeta TMS AI Driven Robotic System in Treatment of Suicidal Bipolar Depression by NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
September 14, 2026
Via Get News
Topics Artificial Intelligence
News headline image
GeNeuro, Inc., an NRx Company (Nasdaq:NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis (ALS)
September 14, 2026
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System
September 11, 2026
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
NRx Pharmaceuticals to Participate in Upcoming Investor Conferences
September 08, 2026
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
FDA First Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies Noted for Suicidal Bipolar Depression Treatment from NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
August 20, 2026
Via Get News
News headline image
NRX Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript ↗
August 17, 2026
Via Benzinga
Topics Earnings
News headline image
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET
August 17, 2026
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
NRx Pharmaceuticals Nears FDA Decision on Preservative-Free Ketamine After Review Clears Hurdles ↗
August 10, 2026
Via MarketBeat
News headline image
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans
August 07, 2026
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
August 07, 2026
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
First Patients Treated via FDA-Cleared Transcranial Magnetic Stimulation, Plus FDA Grant on D-Cycloserine-Based Drug for Depression: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
June 29, 2026
Via Get News
Topics Government
News headline image
New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.
June 27, 2026
From New to The Street
Via ACCESS Newswire
News headline image
NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute
June 25, 2026
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
June 25, 2026
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression
June 22, 2026
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA
June 20, 2026
From New to The Street
Via ACCESS Newswire
News headline image
NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.
June 05, 2026
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option
June 04, 2026
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
These stocks are moving in today's pre-market session ↗
June 03, 2026
Via Chartmill
News headline image
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
June 03, 2026
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
What's going on in today's after hours session ↗
June 02, 2026
Via Chartmill
News headline image
NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
June 02, 2026
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is NRX Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, NRX Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does NRX Pharmaceuticals, Inc. - Common Stock trade on?
NRX Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NRX Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for NRX Pharmaceuticals, Inc. - Common Stock is NRXP on the Nasdaq Stock Market
What is the current price of NRX Pharmaceuticals, Inc. - Common Stock?
The current price of NRX Pharmaceuticals, Inc. - Common Stock is 2.905
When was NRX Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of NRX Pharmaceuticals, Inc. - Common Stock was at 10/02/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap